About
Our mission is to improve equity in health care access and outcomes across geographies, socioeconomics, and demographics. We refuse to accept a world where only a fraction of the population can access the care they need.
Philosophy
Roivant Social Ventures (RSV) is a 501(c)(3) social impact organization started by leaders from Roivant Sciences. RSV takes a venture philanthropy approach to investing in and incubating promising health initiatives. We apply venture capital concepts generally as well as Roivant’s unique company incubation approach to philanthropy in healthcare.
RSV benefits from the infrastructure, talent, and networks of the Roivant Sciences ecosystem, including clinical-stage biotech companies developing 40+ therapies across 14+ disease areas, health tech companies commercializing three marketed technology products, proprietary data and technology platforms, and partnerships with leading institutions.
RSV aims to generate substantial social returns and reinvest financial returns to drive long-term impact. We are flexible in how we work with partners, engage with investees, and leverage our resources.
Investment Strategy
RSV promotes systemic, sustained improvements to the way health care is accessed and delivered. To make investment decisions, RSV analyzes financial and social returns across five dimensions aligned with our core mission, including scale of impact, benefits to underserved populations, and potential for self-sustainability through commercial or other markets.
RSV directs its investments to early-stage opportunities led by stellar teams that have demonstrated strong proof-of-concept aligned with our vision.